Helius Medical Company Insiders

Helius Medical Management Team Effectiveness

The company has return on total asset (ROA) of (0.0399) % which means that it has lost $0.0399 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (3.4428) %, meaning that it created substantial loss on money invested by shareholders. Helius Medical's management efficiency ratios could be used to measure how well Helius Medical manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -3.13 in 2026. Return On Capital Employed is likely to drop to -9.53 in 2026. At this time, Helius Medical's Total Current Liabilities is comparatively stable compared to the past year. Non Current Liabilities Other is likely to gain to about 384.8 K in 2026, whereas Liabilities And Stockholders Equity is likely to drop slightly above 3.9 M in 2026. Common Stock Shares Outstanding is likely to gain to 4,363 in 2026, whereas Net Loss is likely to drop (13.3 M) in 2026. Helius Medical Technologies has a total of 41.3 Million outstanding shares. Helius Medical secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it. Dividend Paid And Capex Coverage Ratio is likely to gain to -1,888 in 2026. Common Stock Shares Outstanding is likely to gain to 4,363 in 2026, whereas Net Loss is likely to drop (13.3 M) in 2026.

Helius Medical Workforce Comparison

Helius Medical Insider Trading History

Helius Medical Notable Stakeholders

String symbol = request.getParameter("s");

The success or failure of an entity such as Helius Medical Techn often depends on how effective the management is. Helius Medical management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Helius management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Helius management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Please note, the imprecision that can be found in Helius Medical's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Helius Medical Technologies. Check Helius Medical's Beneish M Score to see the likelihood of Helius Medical's management manipulating its earnings.

When running Helius Medical's price analysis, check to measure Helius Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Helius Medical is operating at the current time. Most of Helius Medical's value examination focuses on studying past and present price action to predict the probability of Helius Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Helius Medical's price. Additionally, you may evaluate how the addition of Helius Medical to your portfolios can decrease your overall portfolio volatility.